About
Lassogen develops programmable medicines based on engineered lasso peptides to create potent, selective, stable, and safe therapeutic molecules called Lassotides™, targeting diseases inadequately treated by existing therapies.
Explore Lassogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.